Compare BIO-TECHNE Corp (TECH) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs State Street Real Estate Select Sector SPDR ETF — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while State Street Real Estate Select Sector SPDR ETF trades at $45.21. The key difference: BIO-TECHNE Corp pays a 0.45% dividend while State Street Real Estate Select Sector SPDR ETF pays none. Which is the better fit depends on your goals.
| TECH | XLRE | |
|---|---|---|
Market Cap | $11.16B | — |
Sector | Health | Sector/Thematic |
52-Week High | $72.12 | $45.46 |
52-Week Low | $43.31 | $40.01 |
Enterprise Value | $11.24B | — |
Dividend Yield | 0.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
